| Literature DB >> 36056154 |
Alexander W Eyre1, Isain Zapata2, Elizabeth Hare3, Katharine M N Lee4,5, Claire Bellis6,7, Jennifer L Essler8,9, Cynthia M Otto10, James A Serpell11, Carlos E Alvarez12,13.
Abstract
Research on working dogs is growing rapidly due to increasing global demand. Here we report genome scanning of the risk of puppies being eliminated for behavioral reasons prior to entering the training phase of the US Transportation Security Administration's (TSA) canine olfactory detection breeding and training program through 2013. Elimination of dogs for behavioral rather than medical reasons was based on evaluations at three, six, nine and twelve months after birth. Throughout that period, the fostered dogs underwent standardized behavioral tests at TSA facilities, and, for a subset of tests, dogs were tested in four different environments. Using methods developed for family studies, we performed a case-control genome wide association study (GWAS) of elimination due to behavioral observation and testing results in a cohort of 528 Labrador Retrievers (2002-2013). We accounted for relatedness by including the pedigree as a covariate and maximized power by including individuals with phenotype, but not genotype, data (approximately half of this cohort). We determined genome wide significance based on Bonferroni adjustment of two quasi-likelihood score tests optimized for either small or nearly-fully penetrant effect sizes. Six loci were significant and five suggestive, with approximately equal numbers of loci for the two tests and frequencies of loci with single versus multiple mapped markers. Several loci implicate a single gene, including CHD2, NRG3 and PDE1A which have strong relevance to behavior in humans and other species. We briefly discuss how expanded studies of canine breeding programs could advance understanding of learning and performance in the mammalian life course. Although human interactions and other environmental conditions will remain critical, our findings suggest genomic breeding selection could help improve working dog populations.Entities:
Mesh:
Year: 2022 PMID: 36056154 PMCID: PMC9440224 DOI: 10.1038/s41598-022-18698-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Case/control information for dogs in the 2013 TSA cohort.
| Genotyped Dogs | No Genotype | |
|---|---|---|
| Successful | 267 | 180 |
| Eliminated | 29 | 97 |
| Unknown | 0 | 45 |
| Total Dogs | 296 | 322 |
| Male | 158 (17) | 147 (44) |
| Female | 138 (12) | 130 (53) |
Figure 1Principle Component Analysis of genotyped Labrador Retrievers. Principal component 1 (PC1) plotted against PC2. The value in the parentheses represents the % of variance explained by the component.
Figure 2Manhattan and QQ Plots of ROADTRIPS2 output. A Bonferroni cutoff of 2.2 × 10−7 for significant hits and 5 × 10−5 for suggestive hits is mapped. (A) RM output. (B) RW output.
Genome scan for behavioral elimination in 2013 TSA cohort.
| SNP (CanFam3.1) | GWA RM1 | GWA RW1 | Risk Allele | f (Acc.) | f (Elim.) | Genes2 | Brain relevance of top positional candidates (GWAS Catalog and cited sources) |
|---|---|---|---|---|---|---|---|
| chr1.22989459 | G | 0.985 | 1.000 | 12 genes (incl. | NA | ||
| chr1.24927539 | G | 0.985 | 1.000 | ||||
| chr1.25289424 | A | 0.983 | 1.000 | ||||
| chr3.47103534 | 8.18E−01 | G | 0.927 | 0.966 | Human GWA brain traits include several cognitive, schizophrenia, self-injurious behavior. There is extensive knowledge of CHD2 in brain biology and pathophysiology in humans and mice | ||
| chr3.47134935 | 8.54E−01 | G | 0.929 | 0.966 | |||
| chr3.47212502 | 8.18E−01 | G | 0.927 | 0.966 | |||
| chr4.31420247 | 9.08E−03 | G | 0.948 | 0.966 | Human GWA traits incl. schizophrenia and drug use. There is extensive knowledge of NRG3 in brain biology and pathophysiology in humans and mice | ||
| chr6.76632282 | 3.66E−03 | G | 0.951 | 1.000 | DEPDC1-AS1, DEPDC1, | LRRC7: human GWA incl. many cognitive traits, attention deficit hyperactivity disorder, drug use | |
| chr7.66358701 | 6.64E−02 | G | 0.948 | 0.919 | In mouse, highly enriched in brain; highest brain expression in cerebellum in humans and mice (Human ABHD3 introns contain ROCK1 cortex eQTL, ESCO1 thyroid eQTL (GTEx); Mouse ROCK1 dosage affects dendritic spine structure; Human ESCO1 GWA subcortical volume)4 | ||
| chr9.16559175 | 2.51E−01 | G | 0.867 | 0.983 | Human KCNJ2 mutations cause Andersen-Tawil syndrome (OMIM170390), which includes a distinct neurocognitive phenotype with deficits in executive function and abstract reasoning, and may also present mood disorders and seizures5 | ||
| chr13.55534649 | A | 0.976 | 0.983 | 54 genes (incl. | NA | ||
| chr13.57789399 | C | 0.974 | 0.983 | ||||
| chr13.58498102 | G | 0.976 | 0.983 | ||||
| chr13.59658137 | A | 0.976 | 0.983 | ||||
| chr13.59763520 | G | 0.976 | 0.983 | ||||
| chr13.59902870 | 2.43E−01 | A | 0.976 | 1.000 | |||
| chr15.40757218 | 3.86E−03 | A | 0.948 | 1.000 | Many human GWA traits of brain volume and structure, incl. white matter microstructure | ||
| chr19.21040815 | 2.56E−02 | A | 0.938 | 0.966 | ENSCAFG00000004229Note #8, | HS6ST1 was mapped in human GWA of general cognitive ability and has extensive research literature in multiple areas of neuroscience, including neurodevelopment, effects of stress on gene expression and behavior, and reproductive behavior | |
| chr23.33369350 | 1.59E−01 | A | 0.839 | 0.983 | There is one human GWA brain trait: neuroticism. In mice, loss of NCK1 affects dendritic spine density in the amygdala, associated with abnormal stress response and increased anxiety9 | ||
| chr36.25252101 | 7.98E−03 | A | 0.034 | 0.069 | Human brain GWA traits include several cognitive traits and Alzheimers's. Mouse mutants have increased anxiety, abnormal open field behavior and hyperactivity10. There is extensive knowledge of PDE1A in brain biology and pathophysiology in humans and mice | ||
| chr36.25648690 | 7.98E−03 | C | 0.034 | 0.069 |
1RM or RW GWA-test, with multiple testing correction applied for all tests; genome wide significant in bold, suggestive underlined (see Results, Methods).
2Gene annotation of gene(s) nearest single SNPs or spanned for SNP intervals; SNPs within a gene in bold, high brain relevance in any species underlined.
3Three Mb interval is syntenic to three unliked loci in humans. MC2R is predominantly expressed in the adrenal gland.
4Sources of brain enrichment data: mouse BioGPS, human GTEx. Human ABHD3 introns have eQTLs for other genes, including ROCK1 in cortex and ESCO1 in thyroid. Mouse ROCK1 ref., Greathouse, K.M. Brain Structure and Function 223: 4227–4241 (2018).
5KCNJ2 mutation and Andersen-Tawil syndrome description, OMIM170390. Note abutting gene KCNJ16 is enriched in thyroid.
6Many genes at this locus are expressed in salivary glands.
7Near GNPTAB; in human, proximal brain eQTLs for GNPTAB and CHPT1.
8ENSCAFG00000004229 is highly and widely expressed, including in the brain, appears to be a GLUD1/2 retroposed gene.
9The brain-enriched gene RP11-731C17.2 (ENSG00000273486.1) is near. Mouse ref. Diab, A. Neuroscience, 448:107–125 (2020).
10Data source: International Mouse Phenotyping Consortium.
Comprehensive modeling for simultaneous effect size determination of GWAS hits.
| Chromosome | Position (CanFam3.1) | Allele comparison | RM | RW | RM and RW | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Odds ratio | 95% Wald confidence limits | Odds ratio | 95% Wald confidence limits | Odds ratio | 95% Wald confidence limits | ||||||
| 1 | 2,52,89,424 | AA vs. GA | 0.67 | 0.06 | 7.491 | – | – | – | 0.173 | 0.001 | 20.159 |
| 3 | 4,71,34,935 | AA vs. GG | – | – | – | > 999.999 | 39.792 | > 999.999 | > 999.999 | 16.219 | > 999.999 |
| 3 | 4,71,34,935 | AG vs. GG | – | – | – | 0.496 | 0.124 | 1.986 | 0.465 | 0.111 | 1.939 |
| 4 | 3,14,20,247 | AG vs. GG | 1.282 | 0.293 | 5.613 | – | – | – | 1.052 | 0.143 | 7.725 |
| 6 | 7,66,32,282 | AG vs. GG | – | – | – | 0.365 | 0.034 | 3.956 | 0.031 | < 0.001 | 8.034 |
| 7 | 6,63,58,701 | AA vs. GG | 112.194 | 8.222 | > 999.999 | – | – | – | 247.529 | 0.408 | > 999.999 |
| 7 | 6,63,58,701 | AG vs. GG | 0.741 | 0.195 | 2.818 | – | – | – | 1.724 | 0.35 | 8.484 |
| 9 | 1,65,59,175 | AA vs. GG | – | – | – | 1.804 | 0.153 | 21.317 | 1.179 | 0.073 | 18.961 |
| 9 | 1,65,59,175 | AG vs. GG | – | – | – | 0.069 | 0.008 | 0.574 | 0.081 | 0.009 | 0.699 |
| 13 | 5,77,89,399 | AC vs. CC | 2.014 | 0.238 | 17.033 | 14.416 | 1.482 | 140.223 | 8.144 | 0.306 | 216.926 |
| 15 | 4,07,57,218 | AA vs. GA | – | – | – | 2.016 | 0.265 | 15.34 | 7.371 | 0.235 | 230.76 |
| 19 | 2,10,40,815 | AA vs. GA | 1.087 | 0.288 | 4.098 | – | – | – | 1.195 | 0.217 | 6.598 |
| 23 | 3,33,69,350 | AA vs. GG | – | – | – | 2.737 | 0.246 | 30.482 | 4.925 | 0.188 | 129.167 |
| 23 | 3,33,69,350 | GA vs. GG | – | – | – | 0.206 | 0.008 | 5.551 | 0.295 | 0.007 | 13.169 |
| 36 | 2,52,52,101 | AC vs. CC | – | – | – | 5.055 | 1.541 | 16.581 | 4.631 | 1.376 | 15.588 |
Positions are generated from the CanFam3.1 genome assembly.
Brain trait and genomics demographics of behavioral elimination GWA candidate genes.